Cardiopulmonary Disease

New data published in Hypertension have shown that a unique profile of gut bacteria can predict the presence of pulmonary artery hypertension in patients with 83% accuracy.

The FDA has granted breakthrough device designation for the Aria CV Pulmonary Hypertension System, according to a manufacturer press release.